Erytech Pharma SA and Pherecydes Pharma SA M&A Call Transcript
Thank you for standing by, and welcome to the conference call on the proposed merger between Erytech Pharma and Pherecydes Pharma. (Operator Instructions) As a reminder, today's program is being recorded.
And now I'd like to introduce your host for today's program, Gil Beyen, CEO of Erytech. Please go ahead, sir.
Thank you very much. Good afternoon, good morning, bonjour a tous. Thank you for joining us for this conference call and webinar to discuss the proposed merger between Erytech Pharma and Pherecydes Pharma. I'm here with Thibaut du Fayet, the CEO of Pherecydes Pharma; Eric Soyer, the COO and CFO of Erytech Pharma; and Didier Hoch, who is the Chairman of Pherecydes Pharma. Thibaut and I will present the proposed merger, and the four of us will be available for Q&A afterwards.
We announced the intended merger yesterday evening. And the press release, the presentation can be found on the Investors page of both companies' websites and via the link provided in the press release.
Go into
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
